Patient Guide: Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04477486
Status: ACTIVE_NOT_RECRUITING
Condition: Mantle Cell Lymphoma (MCL)
Phase: PHASE2

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Nagoya-shi, Aichi
  • • Nagoya-shi, Aichi
  • • Fukuoka-shi, Fukuoka
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma - Join Clinical Trial NCTNCT04477486

How to Join This Clinical Trial - NCTNCT04477486

Learn how to participate in this PHASE2 trial studying an investigational therapy for Mantle Cell Lymphoma (MCL). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Mantle Cell Lymphoma (MCL). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Mantle Cell Lymphoma (MCL)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04477486 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Nagoya-shi, Aichi 460-0001 - Japan

Status: Contact for availability

Clinical Research Site

Nagoya-shi, Aichi 464-8681 - Japan

Status: Contact for availability

Clinical Research Site

Fukuoka-shi, Fukuoka 812-8582 - Japan

Status: Contact for availability

Clinical Research Site

Sapporo-shi, Hokkaido 060-8648 - Japan

Status: Contact for availability

Clinical Research Site

Kobe-shi, Hyogo 650-0047 - Japan

Status: Contact for availability

Clinical Research Site

Higashi Ibaraki-gun, Ibaraki 311-3193 - Japan

Status: Contact for availability

Clinical Research Site

Kanazawa-shi, Ishikawa 920-8530 - Japan

Status: Contact for availability

Clinical Research Site

Sendai-shi, Miyagi 9808574 - Japan

Status: Contact for availability

Clinical Research Site

Okayama-shi, Okayama 700-8558 - Japan

Status: Contact for availability

Clinical Research Site

Kawagoe-shi, Saitama 350-8550 - Japan

Status: Contact for availability

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Mantle Cell Lymphoma (MCL):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships